Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.39 USD | +13.18% | +26.25% | +3.28% |
May. 02 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
Business Summary
Number of employees: 587
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody-based Therapies
100.0
%
| 1,616 | 100.0 % | 86 | 100.0 % | -94.67% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1,616 | 100.0 % | 86 | 100.0 % | -94.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | - | |
Sung Lee
DFI | Director of Finance/CFO | 53 | 23-03-26 |
Jennifer Towne
CTO | Chief Tech/Sci/R&D Officer | - | Nov. 05 |
Aine M. Hanly
CTO | Chief Tech/Sci/R&D Officer | 54 | 21-02-28 |
George Scangos
BRD | Director/Board Member | 76 | 16-12-31 |
Richard Lepke
IRC | Investor Relations Contact | - | Dec. 31 |
Sasha Ellis
PRN | Corporate Officer/Principal | - | 23-07-09 |
Lynne Krummen
PRN | Corporate Officer/Principal | - | 17-12-31 |
Corporate Officer/Principal | 73 | - | |
Jeff Calcagno
PRN | Corporate Officer/Principal | - | 23-05-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Sigal
BRD | Director/Board Member | 72 | 20-07-01 |
Robert Perez
BRD | Director/Board Member | 59 | 16-12-31 |
Robert More
BRD | Director/Board Member | 56 | 16-08-31 |
Phillip Sharp
BRD | Director/Board Member | 79 | 16-12-31 |
Robert Nelsen
FOU | Founder | 60 | 16-04-06 |
Vicki Sato
CHM | Chairman | 75 | 16-11-30 |
George Scangos
BRD | Director/Board Member | 76 | 16-12-31 |
Director/Board Member | 48 | 19-08-31 | |
Janet Napolitano
BRD | Director/Board Member | 65 | 20-08-27 |
Chief Executive Officer | 56 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 135,843,977 | 119,927,367 ( 88.28 %) | 0 | 88.28 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.28% | 1.41B | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- VIR Stock
- Company Vir Biotechnology, Inc.